SEC Form 4 · accession 0001209191-17-016504
Epizyme, Inc. · EPZM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Ros
Officer — Chief Operating Officer
Period of report
Feb 28, 2017
Accepted (ET)
Mar 2, 2017 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001571498
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.0001F1 | Feb 28, 2017 | A | 1,708 | $6.2135 | A | 1,708 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were acquired under the Epizyme, Inc. 2013 Employee Stock Purchase Plan in connection with offering period ended February 28, 2017.